SILVERBACK THERAPEUTICS INC's ticker is SBTX and the CUSIP is 82835W108. A total of 65 filers reported holding SILVERBACK THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 2.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $34,930,553 | -40.4% | 9,240,887 | +5.7% | 0.74% | -30.1% |
| Q2 2023 | $58,563,943 | +2.9% | 8,740,887 | 0.0% | 1.06% | -5.0% |
| Q1 2023 | $56,903,174 | -23.7% | 8,740,887 | 0.0% | 1.12% | -21.7% |
| Q4 2022 | $74,559,766 | +61.6% | 8,740,887 | 0.0% | 1.43% | +66.4% |
| Q3 2022 | $46,152,000 | +24.5% | 8,740,887 | 0.0% | 0.86% | +27.5% |
| Q2 2022 | $37,061,000 | +20.8% | 8,740,887 | 0.0% | 0.67% | +35.2% |
| Q1 2022 | $30,681,000 | -47.3% | 8,740,887 | 0.0% | 0.50% | -33.6% |
| Q4 2021 | $58,214,000 | -33.3% | 8,740,887 | 0.0% | 0.75% | -22.0% |
| Q3 2021 | $87,234,000 | -67.7% | 8,740,887 | 0.0% | 0.96% | -64.9% |
| Q2 2021 | $270,006,000 | -29.2% | 8,740,887 | 0.0% | 2.73% | -23.4% |
| Q1 2021 | $381,365,000 | -5.8% | 8,740,887 | 0.0% | 3.57% | +0.6% |
| Q4 2020 | $405,053,000 | – | 8,740,887 | – | 3.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SR ONE CAPITAL MANAGEMENT, LP | 3,009,677 | $25,672,544 | 9.37% |
| Nextech Invest Ltd. | 1,910,029 | $16,292,547 | 6.48% |
| K2 PRINCIPAL FUND, L.P. | 2,872,148 | $24,499,422 | 3.72% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 11,077,927 | $94,494,717 | 1.96% |
| Orbimed Advisors | 8,740,887 | $74,559,766 | 1.43% |
| SECTORAL ASSET MANAGEMENT INC | 782,410 | $6,673,957 | 1.29% |
| Rubric Capital Management LP | 2,990,564 | $25,509,511 | 1.11% |
| Oasis Management Co Ltd. | 317,662 | $2,709,657 | 0.54% |
| RA Capital Management | 3,009,678 | $25,672,553 | 0.52% |
| TANG CAPITAL MANAGEMENT LLC | 409,463 | $3,492,719 | 0.51% |